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1102 Abstracts October 2014catheter-directed thrombolysis (CDT). We hypothesized that the Trellis
device would have lower overall hospital costs than CDT.
Methods: This was a retrospective cohort study of consecutive pa-
tients who received thrombolysis for lower extremity DVT from 2010 to
2013 at a private practice vascular surgery group. The observational design
meant no intervention randomization, only a review of performed proce-
dures. Indication included presence of symptomatic thrombosis of the
deep venous system of the lower extremity. Patients underwent pharmaco-
mechanical thrombolysis using Trellis device or only CDT at treating sur-
geon’s discretion. Patients were grouped by procedure method and patient
characteristics and surgical details taken from initial history and physical ex-
amination and operative notes. Analyses were based on comparing procedure
methods and variables associated with hospital costs (ie, Fisher exact test,
Wilcoxon rank sum, or bivariate linear regression with data transformations).
All pairwise comparisons were corrected with Bonferroni method.
Results: There were 57 procedures performed during the study period,
with 10 excluded due to the patient having Paget-Schroetter syndrome, use of
another device (Angiojet), or prior DVT treatment within the previous
month. The ﬁnal study sample consisted of 47 patients, with 79% treated
with the Trellis device (35% of these patients also received CDT). Patient pro-
cedure and outcome data were similar for use of inferior vena cava ﬁlter, com-
plications, length of stay, and direct facility costs (P> .05; Table). Treatment
groups differed on the number of endovascular suite trips (P < .05). Exami-
nation of factors associated with direct facility costs were treatment group
(with Trellis plus CDT costing statistically more than Trellis alone
[r2¼0.17; P ¼ .0292]) and length of stay (r2¼0.39; P < .0001).
Conclusions: This study presents one of the largest documented re-
views of cost data related to the Trellis device. Results revealed treatment
and length of stay as being signiﬁcantly associated with cost. Further ana-
lyses with a greater sample size, along with multivariate analyses, are needed
to best understand cost-predictors related to the treatment of lower extrem-
ity DVT in similar samples.Table. Bivariate comparisons of deep vein thrombosis (DVT) patient
characteristics based on Trellis intervention status (n ¼ 47)
Variablesa
Trellis patient
(n ¼ 37)
Non-Trellis
patient (n ¼ 14) P valueb
Male sex 15 (41) 4 (40) >.9999
Age, years 49 (32-64) 51 (45-58) .9402
Symptoms
Subacute 5 (13) 0 (0) .2446
Acute 28 (76) 7 (70)
Chronic 3 (8) 3 (30)
Unknown 1 (3) 0 (0)
IVC ﬁlter used 21 (57) 8 (80) .1798
Trips to the
endovascular suite
1 (1-2) 2.5 (2-3) <.0010
Complicationc 2 (5) 3 (30) .0573
Hospital length of stay 4 (2-5) 5 (2-8) .9379
Total cost of
hospital stay (USD)
8070
(5618-9833)d
8621
(7422-11798)
.9402
IVC, Inferior vena cava; USD, United States dollars.
aContinuous data are presented as medians (interquartile range) and cate-
goric data as number (%).
bP values are based on the Fisher exact test or the Wilcoxon rank sum test.
cDeﬁned as hematoma, pulmonary embolus, or recurrent deep vein
thrombosis #1 month following treatment.
dMedian direct facility cost of $6068 for Trellis and $9207 Trellis with
catheter-directed thrombolysis.
Fig 1. Age-matchedcontrols (Cntrl) anddeepvenous thrombosis (DVT)+mice.Author Disclosures: J. H. Rinker: None; D. Massop: None; H. L.
Smith: None; P. Wall: None.
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Objectives: Endovascular repair (EVAR) of infrarenal aortic aneu-
rysms (AAAs) is increasingly used in patients with suitable aortic
morphology. Despite improvements in graft design, type II endoleak
(EL-2) from the inferior mesenteric artery (EL-IMA) or lumbar artery
(EL-LA) remains the Achilles’ heel of EVAR. This study evaluated the nat-
ural history of the AAA sac after EVAR. Our hypothesis was that persistent
EL-2 is associated with inferior AAA sac regression.Methods: A retrospective analysis of all nonruptured AAA treated by
elective EVAR using Food and Drug Administration-approved endografts
from January 2005 to December 2008 in our facility was performed. Review
of medical records and preoperative and follow-up computed tomography
angiograms (CTA) at 1, 6, and 12 months were performed. Patients with
type I, III, and IV endoleaks were excluded. Persistent EL-2 was deﬁned
as EL-2 present on CTA at 6 months post-EVAR. AAA size and volume
were analyzed using Aquarius TeraRecon software. Changes in AAA sac vol-
ume at 6 and 12 months were compared in patients (1) with and without
EL-2 and (2) with an occluded vs patent IMA.
Results: The study cohort comprised 197 patients (164 men, 33
women) who were a mean age of 74 years. Mean preoperative AAA diam-
eter was 5.5 cm, and volume was 137.45 cm3 (range 4-11 cm). EL-2 was
present in 27% at completion of EVAR and persisted in 9% at a mean
follow-up of 6 months (range, 4-8 months). EL-LA resolved in 94% on
follow-up vs 55% of EL-IMA (P ¼ .01 by Fisher exact test). Preoperatively,
the IMA was occluded by coils or chronically occluded in 92 patients vs
105 patients who had a patent IMA. At the 6-month follow-up, patients
with an occluded IMA had an EL-2 rate of 2.5% vs 13% in those with a patent
IMA (P ¼ .007 by t-test). Sac volume regression was 39.5% in those with an
occluded IMA vs 29% in those with a patent IMA (P ¼ .04 by Fisher test).
Regression in AAA sac volumewas highly signiﬁcant in patients with occluded
IMA at 60% vs 41.6% at 1 year (P ¼ .0010, two- sided t-test).
Conclusions: The presence of persistent EL-2 after EVAR results in
inferior AAA sac regression. The majority of EL-LA spontaneously throm-
bose by 6 months; however, 45% of EL-IMA are persistent. Consideration
should be given to preoperative coiling of a patent IMA before EVAR.
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